The drug, which was first discovered by Chugai Pharmaceutical and licensed to Eli Lilly in 2018, is called "orforglipron," a word so perplexingly unpronounceable — "or fugly pron"? — that it defies ...

Pharmaceutical company Eli Lilly announced ... its name. The drug, which was first discovered by Chugai Pharmaceutical and licensed to Eli Lilly in 2018, is called "orforglipron," a word so ...

Ricks said reshoring manufacturing capacity for older essential medicines is “a valid thing,” adding that Eli Lilly is “happy ...

CEO David Joyner tells Yahoo Finance he's working to define the company. President Trump ... which suggests that Eli Lilly’s... GLP-1 drug prices are falling. That's good news for patients ...

Eli Lilly said ... oral cancer drug from Scorpion Therapeutics. Get top local San Diego stories delivered to you every morning with our News Headlines newsletter. The company maintained its ...

Eli Lilly and Company ... who follows the company for Gabelli Funds. But he said he thinks big employers will still include both treatments on their lists of covered drugs, leaving the choice ...

Eli Lilly on Thursday reported first-quarter revenue and earnings that topped estimates as demand for its weight loss and diabetes drugs soared, but lowered its full-year profit guidance due to ...

referring to those older drugs. He spoke after Eli Lilly reported first-quarter earnings and 2025 guidance, which did not include estimated effects of the potential pharmaceutical tariffs.

Could the long-running obesity drugs leadership anchored by the Denmark-headquartered Novo Nordisk (NVO) be finally coming to an end? While arch rival Eli Lilly and Company (LLY) spent most of the ...